Cargando…

Could We Have Improved on ADAURA? Refining Global Research Practices to Reduce Cancer Care Disparities

ADAURA was a positive trial, but could changes have improved it and reduced global care disparities?

Detalles Bibliográficos
Autores principales:	West, Howard (Jack), Akhade, Amol, Gyawali, Bishal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2023
Materias:	COMMENTARIES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681540/ https://www.ncbi.nlm.nih.gov/pubmed/37992268 http://dx.doi.org/10.1200/GO.23.00344

Ejemplares similares

CDK 4/6 inhibitors for adjuvant therapy in early breast cancer—Do we have a clear winner?
por: Akhade, Amol, et al.
Publicado: (2022)

ADAURA update: only the end of the beginning
por: Muthusamy, Bharathi, et al.
Publicado: (2023)

Adoring ADAURA: can we cure lung cancer that harbors an EGFR mutation?
por: Melosky, Barbara
Publicado: (2023)

Highlights from Choosing Wisely 2022 for Resource Limited Settings: Reducing Low Value Cancer Care for Sustainability conference, 17th-18th September, Mumbai, India
por: Akhade, Amol, et al.
Publicado: (2022)

ADAURA: The Splash of Osimertinib in Adjuvant EGFR-Mutant Non-small Cell Lung Cancer
por: Ortega-Franco, Ana, et al.
Publicado: (2022)

Deconstructing ADAURA: It is Time to Forgo Adjuvant Platinum-Based Chemotherapy in Resected IB-IIIA EGFR+ NSCLC (Except with RB Alterations?) When Adopting Adjuvant Osimertinib
por: Zhang, Shannon S, et al.
Publicado: (2022)

Me, Too
por: Gyawali, Bishal
Publicado: (2016)

ADAURA, a Bridge Connecting Disease Control with Long-term Survival
por: Zhao, Jing, et al.
Publicado: (2021)

IgE Depletion in Severe Asthma: What We Have and What Could Be Added in the Near Future
por: Incorvaia, Cristoforo, et al.
Publicado: (2017)

Bevacizumab in Advanced Cervical Cancer: Issues and Challenges for Low- and Middle-Income Countries
por: Gyawali, Bishal, et al.
Publicado: (2016)

Endpoints used in phase III randomized controlled trials of treatment options for COVID-19
por: Desai, Aakash, et al.
Publicado: (2020)

Fall in US cancer death rates: Time to pop the champagne?
por: Desai, Aakash, et al.
Publicado: (2020)

Financial toxicity of cancer treatment: Moving the discussion from acknowledgement of the problem to identifying solutions
por: Desai, Aakash, et al.
Publicado: (2020)

Population Health Could Do Far More to Mitigate Health Disparities
por: Braithwaite, R. Scott
Publicado: (2019)

Gender differences in outcomes of cancer patients with COVID: Signal or noise?
por: Wijeratne, Don Thiwanka, et al.
Publicado: (2020)

Acute stroke: we have the treatments and we have the evidence – we need to use them
por: Quinn, Terence J, et al.
Publicado: (2007)

Reply: Have we done the best that we could have done?
por: Arora, Rakesh C., et al.
Publicado: (2020)

COVID-19 and cancer: do we really know what we think we know?
por: Robinson, Andrew G., et al.
Publicado: (2020)

The Patients We Have to See
por: Irwin, Kelly E.
Publicado: (2017)

Do we now have a relevant animal model for breast cancer?
por: Gusterson, Barry, et al.
Publicado: (1999)

Addressing the Mental Health Challenges of Cancer Care Workers in LMICs During the Time of the COVID-19 Pandemic
por: Datta, Soumitra S., et al.
Publicado: (2020)

How could we make nutrition in the intensive care unit simple?
por: Singer, Pierre, et al.
Publicado: (2016)

COVID 19: Have we nailed it?
por: Gogia, Atul
Publicado: (2021)

Fragile, handle with care: refining a key concept for global health and development
por: Diaconu, Karin, et al.
Publicado: (2023)

Flagship Afterthoughts: Could the Human Brain Project (HBP) Have Done Better?
por: Frégnac, Yves
Publicado: (2023)

Advancing global change biology through experimental manipulations: Where have we been and where might we go?
por: Hanson, Paul J., et al.
Publicado: (2019)

Commentary: The times have changed: Are we listening?
por: Grover, A K
Publicado: (2019)

We have to get it right: Ensuring success
por: Mokdad, Ali H., et al.
Publicado: (2020)

The Elimination of Cancer Health Disparities: Are We Ready to Do the Heavy Lifting?
por: Jackson, Jonathan D., et al.
Publicado: (2016)

We need to address health disparities to combat alcohol-related harm
por: Thiele, Maja
Publicado: (2021)

What Global Oncology Needs: Mutual Learning and More Funding
por: Gyawali, Bishal, et al.
Publicado: (2018)

Commentary: We are in the same minimally invasive boat, and we have to row in the same direction
por: Bertolaccini, Luca, et al.
Publicado: (2020)

Commentary: Thoracoscopic-Assisted Rib Plating: Where We Are and What We Have Learned
por: Kim, Seon Hee, et al.
Publicado: (2023)

Decisions at the end of life: have we come of age?
por: Emanuel, Linda, et al.
Publicado: (2010)

Do We Have a Channel Solution for ALS?
por: de Carvalho, Mamede
Publicado: (2015)

Conquering myopia: Have we hit pay dirt?
por: Kesarwani, Siddharth S
Publicado: (2017)

Modeling Water Resources: Have We Got it Right?
por: Havens, Karl E.
Publicado: (2001)

Pancreatic ductal adenocarcinoma epidemiology and risk assessment: Could we prevent? Possibility for an early diagnosis
por: Bekkali, Noor L. H., et al.
Publicado: (2017)

Towards goal-directed therapy of hepatorenal syndrome: we have the tools but we need the trials
por: Mookerjee, Rajeshwar P, et al.
Publicado: (2008)

Could androgens be relevant to partly explain why men have lower life expectancy than women?
por: Schooling, C Mary
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fi4os2i2c4fi4oojefgfu5mst8